Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SamCurt
    Member
    • May 2010
    • 40

    #1

    A Lack of an "Original" SOLiD Paper--why?

    When I tried to prepare a presentation for NGS, I was surprised to find there's no such thing as an "original" paper for SOLiD.

    Usually, there must be a proof-of-concept paper published first, then papers that came out of the platform's beta testers. This is how I have observed with other providers.

    People often quote George Church's paper on the Polonator as the original proof-of-concept of SOLiD, but I disagree. The Polonator could have been a proof-of-concept for Complete Genomics, but IMO, sequential ligation, double interrogation, and colour space, all major features of SOLiD, were never discussed by the Church Lab.

    How can ABI (or Agencourt Personal Genomics) get away with starting a platform's paper trail with a stem-cell paper?
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    It is because there is no requirement that investigators base their discoveries only on completely disclosed methodologies. Arguably there should be. But like any other field of human endeavor, science is rife with contradictory ideologies.

    Ostensibly, your publication of a result requires you to disclose your methods. But if you threw your samples into a black box instrumentation system and results emerged, frequently that will be sufficient disclosure on your part.

    --
    Phillip

    Comment

    • Chipper
      Senior Member
      • Mar 2008
      • 323

      #3
      I think the first SOLiD human genome paper could be regarded as the "original" methods paper since it describes 2BE, emulsions, ligation sequencing etc. http://genome.cshlp.org/content/19/9/1527/suppl/DC1

      Comment

      • SamCurt
        Member
        • May 2010
        • 40

        #4
        Originally posted by Chipper View Post
        I think the first SOLiD human genome paper could be regarded as the "original" methods paper since it describes 2BE, emulsions, ligation sequencing etc. http://genome.cshlp.org/content/19/9/1527/suppl/DC1
        By the time SOLiD v1 has been released for more than a year. Also, this does not explain why most scientist still consider the Polonator paper as the "original" SOLiD paper...

        Comment

        • SeqAA

          #5
          1. you do not need a technology paper.
          2. it's actually quite rare
          3. it's also difficult to get published.

          Comment

          • epistatic
            Senior Member
            • Mar 2009
            • 129

            #6
            Valouev, A. et al. 2008. A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res. 18: 1051–1063.

            Cloonan N, et al. 2008. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods 5:613–619.

            McKernan KJ, et al. 2009. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Research 19 (9): 1527–1541.
            Last edited by epistatic; 11-07-2011, 09:22 AM.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            35 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            25 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            41 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...